Skip to main content
. Author manuscript; available in PMC: 2019 Jul 7.
Published in final edited form as: J Theor Biol. 2018 Apr 1;448:38–52. doi: 10.1016/j.jtbi.2018.03.035

Table 9.

Sensitivity of the tumor net proliferation rate λp on the dFdC pharmacokinetic parameters.

Parameter Description λp perturbed /λp unperturbed
Parameter x 10 Parameter / 10
k1 Plasma elimination rate (min−1) 1.00 1.00
V12 Drug uptake (μM min−1) 1.01 0.44
K12 Half-maximum transport conc. (μM) 0.97 1.01
k21 Drug efflux (min−1) (*) (*)
k2 Inactivation rate (min−1) 0.58 1.08
V2a Activation rate (μM min−1) 5.86 0.14
K2a Half maximum activation conc. (μM) 0.57 1.10
k2a3 Drug-DNA binding (min−1) 6.25 0.14
k32 Drug-DNA release (min−1) (*) (*)
k3 Drug-DNA repair (min−1) (*) (*)
k24 Lysosomal sequestration (min−1) (*) (*)
k42 Lysosomal release (min−1) (*) (*)

(*) Parameter unperturbed value was 0 (Table 5).